Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy

Summary: Cell-based immunotherapy has become the new-generation cancer medicine, and “off-the-shelf” cell products that can be manufactured at large scale and distributed readily to treat patients are necessary. Invariant natural killer T (iNKT) cells are ideal cell carriers for developing allogenei...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yan-Ruide Li, Yang Zhou, Yu Jeong Kim, Yanni Zhu, Feiyang Ma, Jiaji Yu, Yu-Chen Wang, Xianhui Chen, Zhe Li, Samuel Zeng, Xi Wang, Derek Lee, Josh Ku, Tasha Tsao, Christian Hardoy, Jie Huang, Donghui Cheng, Amélie Montel-Hagen, Christopher S. Seet, Gay M. Crooks, Sarah M. Larson, Joshua P. Sasine, Xiaoyan Wang, Matteo Pellegrini, Antoni Ribas, Donald B. Kohn, Owen Witte, Pin Wang, Lili Yang
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	hematopoietic stem cell invariant natural killer T cells cancer immunotherapy allogeneic off-the-shelf cell therapy chimeric antigen receptor allogeneic HSC-engineered iNKT cells Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/64abb953f8fd44bf8d0230b66356f289
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy

Ejemplares similares